Antisense lncRNA PCNA-AS1 promotes esophageal squamous cell carcinoma progression through the miR-2467-3p/PCNA axis.

Hu, Tao; Niu, Yunfeng; Fu, Jianfeng; Dong, Zhiming; He, Dongwei; Liu, Junfeng

Hu, Tao; Niu, Yunfeng; Fu, Jianfeng; Dong, Zhiming; He, Dongwei; Liu, Junfeng.

Afiliación

Hu T; Department of Anesthesiology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Niu Y; Laboratory of Pathology, Hebei Cancer Institute, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Fu J; Department of Anesthesiology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Dong Z; Laboratory of Pathology, Hebei Cancer Institute, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
He D; Laboratory of Pathology, Hebei Cancer Institute, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Liu J; Department of Thoracic Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.

Open Med (Wars) ; 17(1): 1483-1494, 2022.

Article en En | MEDLINE | ID: mdl-36213440

Palabras clave

ESCC; PCNA; PCNA-AS1; miR-2467-3p

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Open Med (Wars) Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Polonia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google